ZBH

SEC source: 0000911916-19-000045 · edgar.xml · derivative · entry 1

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,551

Underlying: Common Stock · 2,551 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs.

SEC source: 0000911916-19-000042 · edgar.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,872

Underlying: Common Stock · 7,872 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 7,872 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 7,872 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 7,872 RSUs.

SEC source: 0000911916-19-000040 · edgar.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,331

Underlying: Common Stock · 1,331 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,331 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,331 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,331 RSUs.

SEC source: 0000911916-19-000038 · edgar.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,443

Underlying: Common Stock · 1,443 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 1,443 RSUs.

SEC source: 0000911916-19-000034 · edgar.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

F1 · price: Represents the purchase of 2,000 shares in multiple transactions ranging in price from $123.614 to $123.63 per share, resulting in a weighted average purchase price of $123.6248. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

SEC source: 0000911916-19-000032 · edgar.xml · derivative · entry 4

GLASSCOCK LARRY C · CIK 0001189793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,092 shares

Expires 2019-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-19-000032 · edgar.xml · nonDerivative · entry 2

GLASSCOCK LARRY C · CIK 0001189793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,593

F2 · price: Represents the purchase of 2,000 shares in multiple transactions ranging in price from $119.99 to $120.19 per share, resulting in a weighted average purchase price of $120.091. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

SEC source: 0000911916-19-000032 · edgar.xml · nonDerivative · entry 1

GLASSCOCK LARRY C · CIK 0001189793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 33 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock between January 29, 2018 and January 31, 2019.

SEC source: 0000911916-19-000030 · edgar.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,085

SEC source: 0000911916-19-000026 · edgar.xml · nonDerivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,215

SEC source: 0000911916-19-000026 · edgar.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,735

SEC source: 0000911916-19-000026 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,615

SEC source: 0000911916-19-000028 · edgar.xml · nonDerivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,650

SEC source: 0000911916-19-000020 · edgar.xml · nonDerivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,250

SEC source: 0000911916-19-000020 · edgar.xml · nonDerivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,150

SEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 4

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,540

SEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 3

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

SEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300

SEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

SEC source: 0000911916-19-000024 · edgar.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,095

F1 · price: Represents the purchase of 2,095 shares in multiple transactions ranging in price from $119.19 to $119.49 per share, resulting in a weighted average purchase price of $119.326. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

SEC source: 0000911916-19-000018 · edgar.xml · nonDerivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

SEC source: 0000911916-19-000011 · edgar.xml · derivative · entry 3

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370

Underlying: Common Stock · 185 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 185 vested on January 3, 2018; 185 vested on January 3, 2019; and of the remaining 370 RSUs, 185 RSUs are scheduled to vest on each of January 3, 2020 and January 3, 2021.

F3 · derivative.expiration_date: The RSUs vest as follows: 185 vested on January 3, 2018; 185 vested on January 3, 2019; and of the remaining 370 RSUs, 185 RSUs are scheduled to vest on each of January 3, 2020 and January 3, 2021.

SEC source: 0000911916-19-000011 · edgar.xml · nonDerivative · entry 2

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

SEC source: 0000911916-19-000011 · edgar.xml · nonDerivative · entry 1

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-19-000009 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,717.329

Underlying: Common Stock · 229.668 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 8.985 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000008 · edgar.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205.726

Underlying: Common Stock · 114.834 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0000911916-19-000007 · edgar.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 411.451

Underlying: Common Stock · 229.668 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0000911916-19-000006 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,631.749

Underlying: Common Stock · 265.931 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 46.233 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000004 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,652.82

Underlying: Common Stock · 229.668 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 10.938 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000005 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,019.896

Underlying: Common Stock · 278.019 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 36.564 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000003 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,767.226

Underlying: Common Stock · 229.668 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 17.437 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000002 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,533.058

Underlying: Common Stock · 265.931 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 20.986 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-19-000001 · edgar.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,201.521

Underlying: Common Stock · 229.668 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.343 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000189 · edgar.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,250

Underlying: Common Stock · 8,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 8,625 of the RSUs vested on December 19, 2018. Of the remaining RSUs, 8,625 will vest on December 19, 2019 and 8,625 will vest on December 19, 2020.

F3 · derivative.expiration_date: 8,625 of the RSUs vested on December 19, 2018. Of the remaining RSUs, 8,625 will vest on December 19, 2019 and 8,625 will vest on December 19, 2020.

SEC source: 0000911916-18-000189 · edgar.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,115

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0000911916-18-000189 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 6

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,140

Underlying: Common Stock · 8,140 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 5

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,095

Underlying: Common Stock · 6,095 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 4

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,700

Underlying: Common Stock · 3,700 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,355

Underlying: Common Stock · 4,355 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 2

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,745

Underlying: Common Stock · 14,745 shares

Expires 2028-12-03

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000188 · edgar.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,345

Underlying: Common Stock · 17,345 shares

Expires 2028-12-03

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 3, 2019.

SEC source: 0000911916-18-000183 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,478.676

Underlying: Common Stock · 181.783 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 7.776 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000182 · edgar.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90.892

Underlying: Common Stock · 90.892 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0000911916-18-000181 · edgar.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181.783

Underlying: Common Stock · 181.783 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0000911916-18-000180 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,319.585

Underlying: Common Stock · 210.486 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 41.613 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000179 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,705.313

Underlying: Common Stock · 220.053 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 32.792 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000178 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,412.214

Underlying: Common Stock · 181.783 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 9.552 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000177 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,520.121

Underlying: Common Stock · 181.783 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 15.468 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0000911916-18-000176 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,246.141

Underlying: Common Stock · 210.486 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 18.635 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.